Financials
- Market Capitalization 366.42 M
- Employee 75
- Founded 2021
- CEO N/A
- Website www.upstreambio.com
- Headquarter Delaware, United States
- FIGI BBG017Y2X923
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2815 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.98 USD | -4.69% | -4.69% | +21.33% | -35.60% | 594.73 M USD | ||
| 2986 | QTTB Q32 Bio Inc. - Common Stock | 15.03 USD | -6.93% | -9.24% | +2.87% | +810.91% | 447.44 M USD | ||
| 3336 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.97 USD | -0.71% | -0.85% | -1.13% | -10.22% | 295.09 M USD | ||
| 3745 | OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 3.79 USD | -1.04% | -5.49% | -3.56% | +54.69% | 153.48 M USD |
Frequently asked questions about Upstream Bio, Inc. Common Stock
What is the Upstream Bio, Inc. Common Stock stock price today?
The current price of Upstream Bio, Inc. Common Stock (UPB) is 6.69. Over the past 24 hours, the stock has changed by -1.47%. Follow the UPB chart for real-time price dynamics.
What is the stock ticker of Upstream Bio, Inc. Common Stock?
Upstream Bio, Inc. Common Stock trades under the ticker UPB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Upstream Bio, Inc. Common Stock stock going up?
UPB has changed by -4.43% over the last week, +5.35% over the last month, and -59.84% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Upstream Bio, Inc. Common Stock?
Upstream Bio, Inc. Common Stock currently has a market capitalization of 366.42 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Upstream Bio, Inc. Common Stock earnings last quarter?
Last quarter, Upstream Bio, Inc. Common Stock reported earnings of -0.73 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Upstream Bio, Inc. Common Stock revenue for the last quarter?
Upstream Bio, Inc. Common Stock reported quarterly revenue of 773 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Upstream Bio, Inc. Common Stock net income for the last quarter?
Upstream Bio, Inc. Common Stock reported net income of -39.7 M for the last quarter. The previous quarter showed -40.59 M, which means net income changed by +2.19%.
How many employees does Upstream Bio, Inc. Common Stock have?
As of the latest available data, Upstream Bio, Inc. Common Stock has 75 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Upstream Bio, Inc. Common Stock stock?
You can buy Upstream Bio, Inc. Common Stock (UPB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Upstream Bio, Inc. Common Stock stock?
Investing in Upstream Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the UPB chart and related analysis on metatrader.com as part of your research.